Results 241 to 250 of about 163,880 (289)
Thiamine-Functionalized Maleated Chitosan: A Novel Bio-Based Adsorbent for Efficient Uptake of Methylene Blue from Aquatic Solutions. [PDF]
Alsohaimi IH +6 more
europepmc +1 more source
Carbon nanoparticles and diatomaceous earth hybrids: A synergistic approach for methylene blue uptake. [PDF]
Occhicone A +6 more
europepmc +1 more source
Comparative Study of Functionalized Cellulose Nanocrystal-Silica Aerogels for Methylene Blue Adsorption. [PDF]
Khumalo N +3 more
europepmc +1 more source
Methylene Blue Injection for Pain Reduction at Iliac Crest Donor Sites: A Randomized Trial and Meta-analysis. [PDF]
Yao C +7 more
europepmc +1 more source
A novel composite of chitosan and Bacillus subtilis exopolysaccharide for the removal of methylene blue from aqueous solutions. [PDF]
Abd-Alla MH +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric Emergency Care, 2021
Abstract Methylene blue has been in medicinal use for centuries and is best known as an antidotal treatment for acquired methemoglobinemia (MetHB). More recently, methylene blue has gained recognition for its efficacious use in the treatment of ifosfamide neurotoxicity and refractory vasoplegic shock in both the pediatric and adult critical ...
Renita S, Pushparajah Mak +1 more
+9 more sources
Abstract Methylene blue has been in medicinal use for centuries and is best known as an antidotal treatment for acquired methemoglobinemia (MetHB). More recently, methylene blue has gained recognition for its efficacious use in the treatment of ifosfamide neurotoxicity and refractory vasoplegic shock in both the pediatric and adult critical ...
Renita S, Pushparajah Mak +1 more
+9 more sources
American Journal of Therapeutics, 2003
Methylene blue finds its major utilization in toxicology in the treatment of methemoglobinemia at a dose of 1 to 2 mg/kg intravenously. By interacting with methemoglobin and the erythrocyte's enzyme systems to reduce back to hemoglobin, methylene blue is a generally safe drug with dose-related hemolytic effects.
Jack, Clifton, Jerrold B, Leikin
openaire +2 more sources
Methylene blue finds its major utilization in toxicology in the treatment of methemoglobinemia at a dose of 1 to 2 mg/kg intravenously. By interacting with methemoglobin and the erythrocyte's enzyme systems to reduce back to hemoglobin, methylene blue is a generally safe drug with dose-related hemolytic effects.
Jack, Clifton, Jerrold B, Leikin
openaire +2 more sources

